Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomos Corporation was a pioneering medical technology company that revolutionized radiation oncology through the development of Intensity Modulated Radiation Therapy (IMRT). The company's flagship PEACOCK system was the first commercially available solution to provide precise, computer-controlled radiation delivery, allowing for higher doses to tumors while sparing adjacent healthy tissue. Nomos played a critical role in establishing the clinical standards for inverse treatment planning and serial tomotherapy. Following its acquisition by North American Scientific in 2004, its technologies were integrated into broader oncology portfolios, eventually becoming part of Best Theratronics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NOMOS.